Enhancing Regenerative Outcomes: Histological Comparison of Hydroxyapatite-Carboxymethylcellulose Combined With Saline vs Platelet-rich Fibrin: A 21-day Study Authors: Julián Hernández, Natalia Ruiz, Brian Ramírez, Rafael Parra-Medina, Andreina Martínez, Agustina Varela Published: 2026 ABSTRACT Background:Calcium hydroxyapatite-carboxymethylcellulose (CaHA-CMC) is a widely used biostimulatory agent that promotes collagen production and tissue remodeling. Platelet-rich fibrin (PRF), rich in growth factors, may enhance this biological response. This study evaluates the subdermal histopathological changes induced by saline solution (SS), PRF, CaHA-CMC + SS, and CaHA-CMC + PRF, with emphasis on early extracellular matrix remodeling and cellular response.Methods:A prospective study was conducted in 5 patients undergoing subdermal injections of the 4 study groups. Tissue samples were obtained at 21 days postinjection. Hematoxylin and eosin staining was analyzed using a semiquantitative digital histomorphometric surrogate (collagen-associated eosinophilic area). Immunohistochemical analysis for CD45 and collagen (types I, III, and IV) was performed in CaHA-containing groups. Statistical comparisons were conducted using the Wilcoxon signed-rank test.Results:CaHA-CMC + PRF demonstrated a significantly higher collagen-associated eosinophilic area compared to the saline control (3.07 times more; 95% CI: 2.10–4.20; P = 0.04), indicating increased collagen-associated matrix deposition. PRF alone showed a mild, nonsignificant increase, whereas CaHA-CMC + SS remained comparable to control. Immunohistochemistry revealed increased CD45+ cellular clustering and more diffuse collagen deposition in the CaHA-CMC + PRF group compared to CaHA-CMC + SS, supporting enhanced cellular recruitment and extracellular matrix organization.Conclusions:The addition of PRF to CaHA-CMC appears to potentiate early subdermal tissue remodeling and cellular response. These findings suggest a synergistic biological effect; however, larger studies are required to confirm long-term clinical implications. Takeaways Question: Does platelet-rich fibrin (PRF) enhance the subdermal biological response induced by calcium hydroxyapatite–carboxymethylcellulose (CaHA-CMC)? Findings: At 21 days postinjection, semiquantitative histomorphometric analysis demonstrated an increased collagen-associated eosinophilic area and greater CD45+ cellular presence in tissues treated with CaHA-CMC + PRF compared to CaHA-CMC + saline, indicating enhanced extracellular matrix remodeling and cellular recruitment. Meaning: The addition of PRF to CaHA-CMC may potentiate early tissue remodeling and cellular response. These findings suggest a biologically enhanced effect, although further studies are required to determine long-term clinical relevance. INTRODUCTION Facial aging signs, such as wrinkles, folds, skin laxity, and uneven or asymmetrical soft tissue distribution,1–3 negatively impact adults’ appearance, often leading to psychological issues like anxiety, isolation, and emotional crises. As a result, many individuals seek ways to reverse these changes.4 In plastic surgery, options include surgical and nonsurgical interventions, such as injectables. Facial injectables represent 73.7% (13,884,172) of all nonsurgical procedures performed by plastic surgeons worldwide, according to the International Society of Plastic Surgery survey. Specifically, calcium hydroxyapatite (CaHA) accounted for 1.9% (350,716) of these procedures.5 CaHA is a facial biostimulator that restores volume but also enhances skin rejuvenation through molecular mechanisms; on a molecular level, CaHA releases calcium ions, which stimulate fibroblast activity, promoting collagen synthesis (types I and III), crucial for maintaining skin structure and elasticity,6,7 the carboxymethylcellulose (CMC) matrix in CaHA acts as a carrier, facilitating the uniform distribution of CaHA microspheres, known for their biocompatibility and minimal inflammatory response; this matrix stabilizes CaHA particles and ensures optimal tissue integration during injection8; together, the CaHA-CMC combination functions as a scaffold supporting tissue regeneration by providing a structure for cellular infiltration and proliferation.6,9 Although CaHA-CMC injections have shown high patient satisfaction in addressing facial aging, combining it with platelet-rich fibrin (PRF) seems to reduce treatment response times to just 3 weeks (less than the 6 wk that the literature reports), improve skin quality, and prolong results.10 This study aimed to evaluate histopathological differences between CaHA-CMC combined with saline solution (SS) and CaHA-CMC combined with PRF in humans, seeking to establish a causal relationship for this hypothesis. METHODS A prospective observational study was conducted using data from 5 patients treated by Dr. Julian Hernandez. The study covered 21 days in February 2024. SUBJECTS The participants consented to the use of abdominal tissues removed during an abdominoplasty as the sampling site for CaHA-CMC combined with SS, CaHA-CMC with PRF, PRF, and SS injections. The participants had no medical history that could influence the study’s results. We included participants who were young and healthy, volunteered to participate in the study, and had an abdominoplasty scheduled for the following month; the exclusion criteria were any medical history, use of any medication, previous abdominal surgery performed, and history of pregnancy; we decided to exclude any participant with these characteristics because we did not want to be biased by variables that we could control or that we knew could affect the results. MATERIALS AND PROCEDURES Twenty-one days before the abdominoplasty, the following injections were administered in the subcuateneus plane: Injection site: The abdominal midline, 14 cm above the pubis, was marked for the injections. Injection site: The abdominal midline, 14 cm above the pubis, was marked for the injections. Right side (5 cm from the midline): 1.5 mL of CaHA-CMC combined with 1.5 mL of standard SS was injected. Right side (5 cm from the midline): 1.5 mL of CaHA-CMC combined with 1.5 mL of standard SS was injected. Left side (5 cm from the midline): 1.5 mL of CaHA-CMC filler diluted with 1.5 mL of PRF was injected. Left side (5 cm from the midline): 1.5 mL of CaHA-CMC filler diluted with 1.5 mL of PRF was injected. Right side (10 cm from the midline): 1.5 mL of standard SS were injected as a control. Right side (10 cm from the midline): 1.5 mL of standard SS were injected as a control. Left side (10 cm from the midline): 1.5 mL of PRF was injected as PRF control. Left side (10 cm from the midline): 1.5 mL of PRF was injected as PRF control. PRF Preparation A venous needle was placed using a blood extraction system, and three blood tubes (30 mL) were collected (sodium citrate anticoagulant tubes are used). A venous needle was placed using a blood extraction system, and three blood tubes (30 mL) were collected (sodium citrate anticoagulant tubes are used). The tubes were centrifuged for 5 minutes at 1000 revolutions per minute; relative centrifugal force = 67.08. The tubes were centrifuged for 5 minutes at 1000 revolutions per minute; relative centrifugal force = 67.08. The yellow fraction of the centrifuged blood was extracted using a syringe, leaving the red blood fraction in the tube. The yellow fraction of the centrifuged blood was extracted using a syringe, leaving the red blood fraction in the tube. Injection Preparation For product mixing, 2 syringes (5 mL) connected by a transfer system were used (5 mL of PRF and 5 mL of CAHA), pushing the substances back and forth to achieve a homogeneous mixture. The same procedure was done for mixing 1.5 mL of SS and 1.5 mL of CAHA. The product was injected in the subcutaneous tissue into 4 circular areas (1 for the CaHA-CMC + SS, 1 for CaHA-CMC + PRF, 1 for PRF alone, and 1 for SS alone) with a 4 cm diameter using a cannula 22G × 50 mm. The injection was performed in a retrograde fanning fashion from the center of the circle toward its outer perimeter. At 21 days postinjection, the samples (skin and subdermal tissues) were collected during the abdominoplasty procedure. The left flap of CaHA-CMC + PRF was labeled “1,” the left flap of PRF alone was labeled “2,” the right flap of SS alone was labeled “3,” and the specimen of CaHA-CMC + SS was labeled “4.” This was only for the surgeon to identify the samples; on the other hand, the pathologist was blinded and had no knowledge regarding the present study. The present study was conducted in the abdominal region of patients undergoing abdominoplasty because it allowed us to access and evaluate the entire area where the product was injected (4 cm X 4 cm). This allowed us to overcome the limitations of previous studies in which small and localized tissue samples had to be obtained in small facial biopsies (4 mm in diameter) due to the difficulty of obtaining tissue samples without the risk of leaving a permanent mark on the patient. Because the study focused on subdermal tissue changes and biological responses, the anatomical site (whether face or abdomen) was not considered a limiting factor for interpreting the results. The 21-day evaluation timepoint was selected based on prior observational data from a survey-based study of 100 patients treated with CaHA. Patients receiving CaHA combined with PRF reported earlier and more sustained effects compared with CaHA diluted with saline, with clinically appreciable changes occurring within the first 2 weeks.10 Based on these findings, tissue sampling at 21 days was chosen to assess early collagen production and subdermal remodeling, earlier than the 6-week period commonly proposed for neocollagenesis assessment. OUTCOMES EVALUATION Outcomes evaluation was performed through a combined qualitative and semiquantitative histopathological and immunohistochemical assessment. All samples were analyzed by a blinded pathologist who had no information regarding treatment allocation or specimen labeling. The evaluation focused on extracellular matrix remodeling, collagen deposition, and cellular infiltration. For hematoxylin and eosin (H&E)-stained sections, a semiquantitative digital histomorphometric surrogate analysis was conducted using the collagen-associated eosinophilic area (CAEA) as an indirect estimate of collagen deposition. This parameter was defined as the proportion of eosinophilic fibrillary tissue relative to the total analyzable subdermal tissue area, excluding background, empty spaces, and nontissue regions. Results were expressed as percentages and normalized to the saline control group. Fold change values were calculated as the ratio between the median value of the parameter in the treatment group and the median value of the corresponding parameter in the reference group (saline control or comparator group). For immunohistochemical analyses, CD45-positive lymphocyte infiltration was assessed semiquantitatively based on cell density, distribution, and clustering patterns, whereas collagen expression (types I, III, and IV) was evaluated based on staining intensity and spatial distribution within septal and interstitial compartments. When applicable, fold changes for these parameters were derived using the same ratio-based approach applied to semiquantitative scoring or estimated signal distribution. Immunohistochemical analyses were specifically performed in the CaHA-containing groups to assess the biological response associated with the presence of the biostimulatory scaffold and to determine the modulatory effect of PRF on CaHA-induced tissue remodeling. These analyses were not extended to saline-only or PRF-only groups, as these conditions lack a structural scaffold capable of inducing sustained extracellular matrix deposition, and preliminary H&E evaluation demonstrated minimal and diffuse changes, limiting the expected added value of immunohistochemical characterization. No statistical analysis was performed with this section due to the lack of quantitative data related to the immunohistochemical analyses. Statistical analysis was conducted using nonparametric methods due to the exploratory nature and limited sample size. Continuous and semiquantitative variables were compared using Wilcoxon signed-rank tests when appropriate, and results were expressed as medians and fold changes relative to control conditions. Confidence intervals for fold changes were estimated using bootstrap resampling methods. A P value less than 0.05 was considered statistically significant. All analyses were performed using Jamovi statistical software (the jamovi project, Australia; version 2.5; Retrieved from https://www.jamovi.org). ETHICAL CONSIDERATIONS Informed consent (surgical procedure, use of images, and use of data for research) was signed before surgery by each patient; patients could refuse to participate in the study or to withdraw consent to participate at any time. This research was done according to the Declaration of Helsinki and received ethical approval from the Quality & Care Institute Ethics Committee. RESULTS A total of 5 patients were included. The mean age of participants was 29.7 years (SD: 3.65), the mean weight was 67.1 kg (SD: 4.20), the mean height was 1.59 m (SD: 0.01), the mean body mass index was 26.5 kg/m2 (SD: 1.88) (see Table 1). Table 1.Anthropometric DataVariableValueSDAge, y29.73.65Weight, kg67.1 kg4.20Height, m1.59 mts0.01Body mass index, kg/m226.51.88 Anthropometric Data Per each patient, 4 specimens were preserved in formalin and were sent to the pathology service for anatomopathological analysis. The first specimen, labeled “1,” measured an average of 8.6 × 6.1 cm, the product was injected in a circle with an area of 4 cm × 4 cm. The second specimen, labeled “2,” measured an average of 7.8 × 6.7 cm; the product was injected in a circle of the same area. The third specimen, labeled “3,” measured an average of 8.2 × 6.1 cm; the product was injected in a circle of the same area. The unlabeled specimen measured an average of 6.9 × 6.3 cm; the product was injected in a circle of the same area. Upon palpation and serial sectioning, specimen 1 exhibited greater induration and resistance to being cut by the pathologist in all the 5 specimen 1 samples versus all the other specimens. Serial sections were obtained from all specimens in each patient, focusing on subdermal fibrotic areas for histological evaluation. H&E staining confirmed the presence of calcium hydroxyapatite microspheres in both CaHA-treated groups, with a relatively homogeneous distribution within the tissue. A semiquantitative digital histomorphometric surrogate analysis was performed using the CAEA to estimate collagen deposition. The CaHA-CMC + PRF group demonstrated the highest CAEA values, showing approximately 3.1 times greater CAEA compared to the saline control group (95% CI: 2.1–4.2; P = 0.04). The PRF-only group exhibited a mild increase (~1.15 times greater than control; 95% CI: 0.9–1.4; P = 0.21), whereas the CaHA-CMC + saline group did not demonstrate a statistically significant difference compared to control (~0.99 times greater; 95% CI: 0.8–1.2; P = 0.87). Additionally, the CaHA-CMC + PRF specimens showed increased cellular infiltration compared to all other groups. Comparable distribution of CaHA microspheres was observed across CaHA-treated specimens. These findings should be interpreted as a surrogate histomorphometric estimate derived from H&E staining rather than a collagen-specific quantification (Figs. 1–4). H&E staining: SS—subdermal tissue. A, Subdermal adipose tissue shows preserved adipocyte architecture with thin fibrous septa and minimal eosinophilic fibrillary material. B, A similar pattern is observed, with scarce diffuse cellularity and no evident clustered inflammatory response or organized extracellular matrix remodeling. H&E staining: PRF—subdermal tissue. A, Subdermal tissue shows preserved adipocyte morphology with increased eosinophilic fibrillary material within the interstitial spaces. B, Fibrin-like eosinophilic material is observed with mild diffuse cellularity, without evident clustered inflammatory infiltration or extensive extracellular matrix remodeling. H&E staining: CaHA-CMC + SS—subdermal tissue. A, CaHA microspheres are distributed within the subdermal tissue, with mild surrounding eosinophilic fibrillary material. B, Microspheres remain dispersed within interstitial spaces, with sparse diffuse cellularity and limited extracellular matrix remodeling. H&E staining: CaHA-CMC + PRF subdermal tissue. A, CaHA microspheres are embedded within a prominent eosinophilic fibrillary matrix with increased cellularity around the injected material. B, Eosinophilic matrix extends through interstitial and septal regions, with cellular clustering suggestive of an enhanced early tissue remodeling response. Immunohistochemical analysis for CD45 was performed in the CaHA-containing groups (CaHA-CMC + saline and CaHA-CMC + PRF) to evaluate the cellular response associated with the presence of the biostimulatory material and to assess whether the addition of PRF modifies the immune response induced by CaHA. The CaHA-CMC + PRF specimens demonstrated a markedly increased density of CD45-positive lymphocytes, characterized by clustered, perivascular, and perimaterial distribution patterns, indicating an active cellular recruitment response. In contrast, the CaHA-CMC + saline group showed sparse and scattered CD45-positive cells, consistent with a lower level of immune cell infiltration. A semiquantitative assessment of CD45-positive cells demonstrated that the CaHA-CMC + PRF group exhibited approximately 5–7 times higher lymphocyte presence compared to the CaHA-CMC + saline group. This difference should be interpreted as an exploratory semiquantitative estimate based on immunohistochemical signal distribution rather than an absolute cellular count (see Table 2; Figs. 5, 6). Table 2.Semiquantitative Histomorphometric Analysis of CAEAGroupCAEA, Median (IQR)Fold Change vs SS95% CIWilcoxon Signed Rank and PSaline (SS)11.1 (10.4–11.8)1.0 (Ref)——PRF12.8 (12.1–13.5)1.150.90–1.40z = −1.25P = 0.21CaHA + SS11.0 (10.2–11.7)0.990.80–1.20z = −0.16P = 0.87CaHA + PRF34.1 (31.5–36.2)3.072.10–4.20z = −2.05P = 0.04**Values represent semiquantitative digital histomorphometric surrogate estimates derived from H&E-stained sections.**Statistical significance. Semiquantitative Histomorphometric Analysis of CAEA Values represent semiquantitative digital histomorphometric surrogate estimates derived from H&E-stained sections. Statistical significance. Immunohistochemical staining (CD45): CaHA-CMC + SS subdermal tissue CD45-positive cells are sparsely distributed throughout the tissue, with a predominantly diffuse pattern and no evident clustering or perivascular concentration. This staining pattern is consistent with limited lymphocytic infiltration and a modest cellular response. Immunohistochemical staining (CD45): CaHA-CMC + PRF subdermal tissue CD45-positive cells are present within the subdermal tissue, showing focal clustering in perivascular and perimaterial regions. This pattern indicates increased lymphocytic infiltration and enhanced cellular recruitment in the CaHA-CMC + PRF group. Immunohistochemical staining for collagen types I, III, and IV was performed in the CaHA-containing groups (CaHA-CMC + saline and CaHA-CMC + PRF) using a Ventana (Roche) platform to evaluate extracellular matrix remodeling associated with the presence of the biostimulatory scaffold and to assess whether the addition of PRF enhances collagen production induced by CaHA. The CaHA-CMC + PRF specimens demonstrated a markedly increased collagen expression compared to the CaHA-CMC + saline group, characterized by a more intense and widespread immunopositive signal with a diffuse and continuous distribution pattern extending beyond fibrous septa into the interstitial matrix. In contrast, the CaHA-CMC + saline group exhibited a weaker and more discontinuous staining pattern, predominantly localized to septal structures, consistent with a more limited extracellular matrix remodeling response. A semiquantitative assessment of immunohistochemical signals suggested that the CaHA-CMC + PRF group exhibited approximately 3–5 times greater collagen expression compared to the CaHA-CMC + saline group. These findings should be interpreted as an exploratory semiquantitative estimate based on staining distribution and intensity rather than an absolute quantification of collagen content. Immunohistochemical analysis was not performed in the saline-only and PRF-only groups, as these conditions lack a structural scaffold capable of inducing sustained and localized extracellular matrix deposition comparable to CaHA-based treatments, and prior histological evaluation with H&E demonstrated minimal and diffuse collagen-associated changes, making additional immunohistochemical characterization unlikely to provide meaningful comparative insights within the mechanistic scope of this study (see Table 3; Figs. 7, 8). Table 3.Semiquantitative Immunohistochemical AnalysisParameterGroupDistribution PatternInterpretationFold ChangesCD45CaHA + SSSparse, scatteredLow cellular infiltrationReferenceCaHA + PRFClustered, perivascular and peri materialIncreased cellular recruitment5–7×Collagen (types I, III, and IV)CaHA + SSMild, septal, discontinuousLimited ECM remodelingReferenceCaHA + PRFDiffuse, interstitial and septal, continuousEnhanced ECM remodeling3–5×Immunohistochemical results are based on semiquantitative assessment of staining intensity, spatial distribution, and cellular clustering patterns. Fold changes represent estimated ratios derived from comparative signal density rather than absolute quantitative measurements. Statistical testing was not performed due to the limited sample size and exploratory nature of the analysis.ECM, extra cellular matrix. Semiquantitative Immunohistochemical Analysis Immunohistochemical results are based on semiquantitative assessment of staining intensity, spatial distribution, and cellular clustering patterns. Fold changes represent estimated ratios derived from comparative signal density rather than absolute quantitative measurements. Statistical testing was not performed due to the limited sample size and exploratory nature of the analysis. ECM, extra cellular matrix. Immunohistochemical staining (collagen types I, III, and IV): CaHA-CMC + SS subdermal tissue. A, Mild collagen immunostaining is mainly localized to septal and periadipocyte regions, with preservation of native adipose architecture. B, Collagen staining remains limited and discontinuous, without diffuse interstitial extracellular matrix remodeling. Immunohistochemical staining (collagen types I, III, and IV): CaHA-CMC + PRF subdermal tissue. A, Collagen immunostaining shows a diffuse pattern involving septal and interstitial regions, with staining extending around adipose lobules and injected material. B, Higher-magnification view demonstrates more continuous collagen immunopositivity within the extracellular matrix, consistent with enhanced matrix remodeling in the CaHA-CMC + PRF group. DISCUSSION This study provides histopathological and immunohistochemical evidence suggesting that the combination of CaHA-CMC with PRF enhances extracellular matrix remodeling and cellular recruitment at 21 days postinjection compared to CaHA-CMC diluted with SS. Rather than establishing definitive clinical superiority, these findings should be interpreted as exploratory evidence supporting a potential synergistic interaction between both components. The biological activity of CaHA-CMC is well established and is primarily mediated through calcium ion release, which stimulates fibroblast activation and promotes the synthesis of type I and III collagen, key elements for dermal structure and elasticity.6,7 In this study, CaHA-containing groups demonstrated collagen-associated eosinophilic deposition on H&E staining, supporting its role as a biostimulatory scaffold. However, the addition of PRF was associated with a substantially greater effect, with semiquantitative analysis showing an increased CAEA compared to both control and CaHA + saline groups. These findings were further supported by immunohistochemical analysis. Collagen staining for types I, III, and IV demonstrated a more intense and diffuse expression pattern in the CaHA-CMC + PRF group, extending beyond septal structures into the interstitial matrix. This suggests that PRF not only enhances collagen production but may also promote more homogeneous and functionally relevant extracellular matrix remodeling. Given that PRF contains a high concentration of growth factors such as platelet-derived growth factor, vascular endothelial growth factor, and transforming growth factor-beta, its role in amplifying fibroblast proliferation, angiogenesis, and matrix synthesis is biologically plausible.11–14 In addition to matrix remodeling, a marked increase in CD45-positive lymphocyte infiltration was observed in the CaHA-CMC + PRF group compared to CaHA-CMC + saline; this finding suggests that PRF enhances the cellular response associated with CaHA, potentially creating a more active regenerative microenvironment; the fibrin network within PRF provides a 3-dimensional scaffold that facilitates cell migration and supports the sustained release of growth factors, which may explain the increased cellular clustering and perivascular distribution observed in this group.15–17 The combination of these findings supports a mechanistic model in which PRF amplifies the biological effects of CaHA through both structural and biochemical pathways. CaHA provides a stable scaffold and mechanical stimulus for fibroblast activation, whereas PRF contributes a bioactive matrix rich in growth factors, promoting cellular recruitment and extracellular matrix deposition. This dual mechanism may explain the observed increase in both collagen deposition and immune cell infiltration. From a clinical perspective, these results suggest that the combination of CaHA-CMC with PRF may enhance early tissue remodeling processes compared to CaHA-CMC with SS; this could translate into improved skin quality, faster integration, and potentially longer-lasting outcomes, as previously suggested in clinical observations.10 Additionally, PRF may reduce the rapid volume loss associated with saline dilution, a phenomenon often described as the “Cinderella effect,” thereby improving early patient satisfaction. The autologous nature of PRF also ensures high biocompatibility and minimizes the risk of adverse immune reactions.18,19 LIMITATIONS Although the findings of this study provide preliminary insight into the interaction between CaHA-CMC and PRF, several limitations must be acknowledged. First, the small sample size (n = 5) and the absence of randomization limit the generalizability of the results and preclude definitive conclusions regarding treatment efficacy. Second, the semiquantitative nature of the histomorphometric analysis, particularly the use of CAEA derived from H&E staining, represents a surrogate estimate of collagen deposition rather than a specific or absolute quantification. Although immunohistochemical analysis for collagen types I, III, and IV provided more specific information, these assessments were limited to CaHA-containing groups, restricting direct comparison across all treatment conditions. Furthermore, immunohistochemical findings were interpreted using semiquantitative assessment due to the limited sample size, which may introduce variability in the estimation of cellular infiltration and collagen expression. Future studies should incorporate larger, randomized cohorts, standardized quantitative histological techniques, and extended follow-up periods to validate these findings. Additional research exploring combinations of CaHA-CMC + PRF with other regenerative strategies, such as hyperbaric oxygen therapy,20 may further expand the potential applications of this approach. CONCLUSIONS This study provides exploratory histopathological and immunohistochemical evidence suggesting that the combination of CaHA-CMC with PRF may enhance early subdermal tissue remodeling compared to CaHA-CMC diluted with SS. The observed increases in CAEA, collagen types I, III, and IV expression, and CD45-positive cellular infiltration support the hypothesis of a synergistic interaction between a biostimulatory scaffold and a bioactive matrix. However, these findings should be interpreted with caution given the small sample size, semiquantitative nature of the analyses, and short follow-up period. Rather than demonstrating definitive clinical superiority, this study should be considered hypothesis-generating, providing a biological rationale for the combined use of CaHA-CMC and PRF. DISCLOSURE The authors have no financial interest to declare in relation to the content of this article.